节点文献

多烯紫杉醇免疫脂质体对Lovo细胞的靶向放射增敏研究

Radiosensitivity of Lovo Cell Enhanced by Immunoliposomal Docetaxel

【作者】 王庆伟

【导师】 徐从高;

【作者基本信息】 山东大学 , 内科学, 2005, 博士

【摘要】 研究背景: 多烯紫杉醇是一种半化学合成的紫杉醇,它可促进微管聚集,稳定微管结构,阻止微管解聚。多烯紫杉醇为细胞周期特异的药物,并由此发挥放射增敏作用。但因选择性较差,对正常组织的毒副作用限制其应用范围。脂质体作为药物的载体可以提高药物的治疗指数,但脂质体本身无特异靶向性,在脂质双分子层中掺入对特异细胞具有选择性和亲合性的配体,利用细胞对配体的识别可得到专一性作用于靶细胞的靶向脂质体。将天然或修饰的抗体分子偶联到含有适当功能基团的脂质体上,形成免疫脂质体。作为药物载体具有独特的优点,目前它已应用于临床,并取得满意的效果。放射治疗是结直肠癌治疗的重要手段之一,然而结直肠癌为相对放射抗拒的肿瘤。常规的放射增敏剂由于选择性较差,对正常组织毒副作用限制了其应用范围。通过肿瘤特异性抗原抗体对增敏剂的靶向作用,可增加放射增敏的选择性。CEA一种位于肿瘤细胞膜上的肿瘤相关抗原,在大肠癌中表达最强,LoVo细胞为表达CEA的人结肠腺癌细胞株。 研究目的: 本研究采用一种将特异性CEA抗体粘附于与多烯紫杉醇脂质体相连的PEG末端的新方法,制备空间稳定免疫脂质体,提高其对靶向组织的选择性。降低对正常组织的非特异毒性反应;在研制的多烯紫杉醇免疫脂质体新剂型基础上,评价其对LoVo细胞的放射增敏作用,放射敏感性与肿瘤细胞的凋亡倾向及细胞周期的的关系。观察其对细胞凋亡相关蛋白表达的影响。为多烯紫杉醇免疫脂质体放射增敏作用的应用提供实验依据。

【Abstract】 BacgroundDocetaxel is a semisynthetic taxane that affects polymerized tubulin both topromote microtubule formation and to inhibit its disassembly. Docetaxel is a phase-specific agent that may offer the potential for enhancement of radiosensitization. As the poor targeted, the toxities to the normal tissues limit the extents of application. Liposomes can enhance the therapeutic expontent as the carries of druges, but it has no targeted. Colorectal cancer is one of the most common malignant diseases in the world. In the treatment of colorectal cancer, local recurrence is a major problem. To improve overall survival and reduce local recurrence rate after surgery, additional radiotherapy was given either preoperatively or postoperatively.In order to enhance its beneficial radiosensitizing capability, docetaxel was incorporated into liposomes with antibody conjugate for the targeted delivery to specifical cancer cells. Combination sterical stabilization with targetability, docetaxel immunoliposomes were prepared. In this study, we attempt to investigate the radiosensitization of colon carcinomas targeting with docetaxel liposome conjugated to antibody specific for carcinoembryonic antigen (CEA). The aim of this study is selective delivery of docetaxel and enhancing the radiation sensitivity on human colon cancer cell. In order to increase radiotherapy effects of local tumor and to improve both the quality of life and overall survival, radiosensitizer should be targeted to deliver into the tumor and limited to normal tissue. This workshopconsidered a new approach by use targeted radiosensitizer to improve radiotherapy. MethodsPreparation of immunoliposomal docetaxel: A new PEG-PE derivative that had been endgroup-functionalized with cyanuric chloride was first synthesized. Anti-carcinoembryonic antigen (CEA) monoclonal antibody can simply be coupled to this membrane anchor in mild basic conditions (pH 8.8) without the need for previous antibody derivatizations. The entrapment efficiency and the quality of prepared docetaxel immunoliposomes were evaluated. In vitro cell association of docetaxel immunoliposomes binding was determined. The function and activity of the coupling anti-CEA monoclonal antibody was also analyzed.Enhancement of radiosensitivity by immunoliposomal docetaxel in human colon adenocarcinoma LoVo cell: The optimal combination of immunoliposomal docetaxel and radiation in vitro was obtained by the cytotoxicity evaluation of immunoliposomal docetaxel and a single radiation treatment in human colon adenocarcinoma cell lines.The effect of immunoliposomal docetaxel in combination with radiation on the expression of apoptosis-related proteins and EGFR : The expression of apoptosis-associated proteins p53, Bcl-2 and Bax were detected by flow cytometry in LoVo cells. Fas -. FasL and survivin proteins were detected by immunohistochemical staining and were quantified using semi-quantitative analysis by image analysis system. Epidermal growth factor receptor (EGFR) was detected with Western blot. Carcinoembryonic antigen expressed in cell cultures was assessed by Sandwhich ELISA. ResultsThe mean particle size of docetaxel immunoliposomes was 213±17.4 nm. Encapsulation efficiency of docetaxel immunoliposomes was 97.6 %. Using flow cytometry to analyze the targetability of docetaxel immunoliposomes show a higher degree of in vitro cell binding compared to conventional docetaxel liposomes. Enzyme-linked immunosorbent assay (EILSA) indicated that the immunoreactivity ofantibodies on liposome was retained completely. A stable and selective targeted agent has been achieved by biophysical evaluation of docetaxel immunoliposomes. The MTT assay indicated the cellular growth inhibitory rates were dose-response and time- response. HT29 cells shown a strong cytotoxicity to immunoliposomal docetaxel compared with LoVo cells. Both cell lines showed a dose-response to a single radiation shot. The combined treatment LoVo cells were tested by clonogenic assay. 2nM, lOOnM immunoliposomal docetaxel enhanced radiosensitivity ( SERDo. SERoq were 1.70, 1.78 and 1.47, 1.63 respectivly), but 2nM liposomal docetaxel was less radiosensitive ( SERdo, SERoq werel.02, 1.03). Flow cytometric analysis showed the concomitant effect of 2nM docetaxel with 2Gy radiation exposure, significantly increased the percentage of G2-M cells and induced apoptosis (P O.01), by comparison with non-targeted docetaxel. TUNEL staining cells revealed a condensed TUNEL-positive nucleus and reflected apoptotic cell death. Immunoliposomal docetaxel induced the numbers of TUNEL positive nuclei increased (43.6%), in contrast to liposomal docetaxel (17.7 %). Targeted docetaxel also increased the DNA ladder formation in the combined treatment LoVo cells. Morphological evidence of apoptotic cells could be distinguished under the fluorescence microscope after staining with Hochest 33342. Many nuclear fragments were observed in LoVo cells with docetaxel radiosensitization The Immunoliposomal docetaxel treated LoVo cells showed Bax increased, but no significant changes in the expression of p53 and bcl-2 proteins were observed. By the effect of docetaxel radiosensitization, FasN FasL in LoVo cells were expressed higher than LoVo cells with non-targeted docetaxel treatment (p<0.01). Combined with radiation, docetaxel could inhibit the expression of survivin. EGFR was down-regulated by Immunoliposomal docetaxel. After exposures of docetaxel and radiation , carcinoembryonic antigen was increased in the cell cultures. ConclusionA stable and selective targeted agent has been achieved by biophysical evaluation of docetaxel immunoliposomes. A stable and selective targeted agent has beenachieved by biophysical evaluation of docetaxel immunoliposomes. The immunoliposomal docetaxel is able to enhance the radiosensitivity in LoVo cell. The different pathways involved in promotion of apoptosis undergo docetaxel radiosensitization.

  • 【网络出版投稿人】 山东大学
  • 【网络出版年期】2005年 08期
节点文献中: 

本文链接的文献网络图示:

本文的引文网络